NCT02289248View on ClinicalTrials.gov

Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Depression
Interventions
DRUG

Ketamine

Subjects will undergo a twice weekly two week course of IV infusions of ketamine

BEHAVIORAL

Cognitive Behavioral Therapy (CBT)

Subjects will undergo twice weekly CBT for a total of 8 weeks

Trial Locations (2)

06519

Connecticut Mental Health Center, New Haven

Yale Psychiatric Hospital, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT02289248 - Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine | Biotech Hunter | Biotech Hunter